SAN FRANCISCO, May 5, 2016 - A new study of more than 10,000 patients treated long term with the blood thinner, warfarin, reveals higher rates of dementia for patients with atrial fibrillation versus non-AF patients
The study, by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City, found that atrial fibrillation patients treated long term with warfarin had higher rates of dementia, Alzheimer's disease and vascular dementia compared to anticoagulated non-atrial fibrillation patients.